Cacng6 is a regulatory subunit of voltage-gated L-type calcium channels (VLCCs), which mediate Ca²⁺ influx in excitable cells. Its primary roles include:
Channel Stabilization: Maintains calcium channels in an inactive state, modulating Ca²⁺ signaling .
AMPAR Regulation: Facilitates trafficking and gating of AMPA-selective glutamate receptors (AMPARs) to synaptic membranes, influencing neuronal plasticity .
Disease Associations: Linked to schizophrenia (SCZ) and aspirin-intolerant asthma (AIA) through genetic polymorphisms .
Recombinant Cacng6 is pivotal in:
Calcium Channel Studies: Investigating VLCC modulation in cardiac, muscular, and neuronal tissues.
Neurological Disorders: Assessing SCZ risk via SNPs (e.g., rs192808 in CACNG6) .
Drug Development: Screening compounds targeting calcium channelopathies or AMPAR dysregulation.
Toxicology: Evaluating chemical-induced gene expression changes (e.g., bisphenol A, cisplatin) .
| Gene Pair | SNP Interaction | P-Value | Biological Implication |
|---|---|---|---|
| CACNG6–CACNG5 | rs192808 × rs2048137 | Synergistic risk for schizophrenia |
Storage Stability: Avoid repeated freeze-thaw cycles; aliquot for long-term storage .
Activity Validation: Functional assays (e.g., electrophysiology, AMPAR trafficking assays) are recommended due to its regulatory role .
Related Products:
CACNG6 (calcium voltage-gated channel auxiliary subunit gamma 6) is a member of the voltage-dependent calcium channel gamma subunit family. Structurally, it functions as an auxiliary protein that modulates the properties of voltage-gated calcium channels. The protein contains several transmembrane domains and plays a crucial role in regulating calcium influx across cellular membranes .
For experimental investigation of structure-function relationships, researchers typically employ:
Site-directed mutagenesis to identify critical functional residues
Electrophysiological techniques (patch-clamp recordings) to measure channel properties
Fluorescence resonance energy transfer (FRET) to examine protein-protein interactions within the channel complex
When comparing rat and human CACNG6 in experimental contexts, researchers should consider:
Sequence homology analysis shows conservation of key functional domains but species-specific variations in regulatory regions
Electrophysiological properties may differ subtly between species, particularly in activation and inactivation kinetics
Expression patterns across tissues show some divergence between rat and human models
For cross-species experiments, implement:
Western blotting with species-specific antibodies
Species-appropriate positive controls in functional assays
Careful interpretation of pharmacological responses that may vary between species
For optimal recombinant rat CACNG6 expression:
Expression System Selection:
Mammalian systems (HEK293, CHO cells) preserve post-translational modifications
Insect cell systems (Sf9, High Five) offer higher yield but different glycosylation patterns
Bacterial systems are challenging due to membrane protein properties but can be optimized with fusion tags
Purification Strategy:
| Step | Method | Critical Parameters |
|---|---|---|
| Extraction | Detergent solubilization | Detergent type and concentration |
| Capture | Affinity chromatography | Tag position (N vs C-terminal) |
| Polishing | Size exclusion chromatography | Buffer composition, pH |
| Quality Control | SDS-PAGE, Western blot, Mass spectrometry | Purity assessment criteria |
Functional Validation:
Reconstitution into liposomes for ion flux assays
Co-immunoprecipitation with known binding partners
Circular dichroism to verify proper folding
CACNG6 demonstrates distinctive expression patterns across rat tissues:
Highest expression observed in lung tissues
Moderate expression in brain regions, particularly in excitable neural tissues
Lower expression in cardiac and skeletal muscle compared to other calcium channel subunits
For expression analysis, researchers should:
Use quantitative RT-PCR with tissue-specific reference genes
Implement RNAscope or in situ hybridization for spatial resolution within tissues
Validate with immunohistochemistry using specific antibodies verified against knockout controls
Consider developmental stage variations when designing experiments
To differentiate between endogenous and recombinant CACNG6:
Antibody-based approaches:
Use epitope tags (HA, FLAG, Myc) on recombinant proteins
Employ antibodies targeting species-specific regions for distinction
Implement dual-labeling immunofluorescence with tag-specific antibodies
Genetic approaches:
Design primers spanning vector-insert junctions for PCR detection of recombinant transcripts
Consider fluorescent protein fusions for live imaging (verify functionality)
Use CRISPR/Cas9 knockin strategies for endogenous tagging
Functional approaches:
Utilize electrophysiological signatures of overexpression
Implement inducible expression systems to control recombinant levels
CACNG6 interacts with several proteins within calcium channel complexes and beyond:
Primary interactions:
α1 subunits of voltage-gated calcium channels
β subunits that modulate channel trafficking
α2δ auxiliary subunits that affect channel biophysical properties
Secondary interactions:
To identify novel interaction partners:
Apply proximity labeling techniques (BioID, APEX)
Implement co-immunoprecipitation followed by mass spectrometry
Use yeast two-hybrid screening with membrane-specific adaptations
The interaction between CACNG6 and other calcium channel subunits exhibits tissue-specific variations that should be considered when designing experiments.
CACNG6 contains multiple phosphorylation sites, including documented sites at S188 and S195 , which may regulate channel function:
Detection methods:
Phospho-specific antibodies for key residues
Phos-tag SDS-PAGE for mobility shift detection
Mass spectrometry with phosphopeptide enrichment
Functional assessment:
Site-directed mutagenesis (phosphomimetic mutations: S→D; phospho-null mutations: S→A)
Patch-clamp electrophysiology before and after kinase activator/inhibitor treatment
Live cell imaging with phosphorylation biosensors
Kinase identification:
| Predicted Kinase | Target Residue | Consensus Sequence | Validation Method |
|---|---|---|---|
| PKA | S188 | RXXS | In vitro kinase assay |
| CaMKII | S195 | RXXS/T | Pharmacological inhibition |
| PKC | Multiple sites | S/TXK/R | Genetic approaches |
Research suggests CACNG6 may contribute to neuropsychiatric conditions:
Schizophrenia associations:
Mechanistic considerations:
For investigating neuropsychiatric connections:
Implement conditional knockout models targeting specific brain regions
Assess behavioral phenotypes using validated schizophrenia endophenotype paradigms
Utilize human-derived neural models (iPSC-derived neurons) carrying relevant polymorphisms
Note: A previous publication suggesting CACNG6 involvement in cardiac hypertrophy through miR-296-5p regulation has been retracted due to concerns regarding data reliability . Therefore, researchers should approach this area with caution.
When investigating potential cardiac roles:
Experimental approaches:
Cardiomyocyte-specific conditional expression/deletion models
Pressure-overload models with careful temporal analysis of CACNG6 expression
Calcium imaging in isolated cardiomyocytes from relevant models
Essential controls:
Multiple independent methods for measuring hypertrophic responses
Rigorous statistical analysis with appropriate sample sizes
Independent validation in different model systems
Modern approaches to investigating CACNG6 dynamics include:
Advanced imaging techniques:
Super-resolution microscopy (STORM, PALM) for nanoscale localization
Single-particle tracking for mobility analysis within membranes
FRET-based sensors for conformational changes
Electrophysiological approaches:
Simultaneous patch-clamp and fluorescence imaging
Optogenetic coupling to manipulate channel activity
Automated high-throughput electrophysiology for pharmacological screening
Computational modeling:
Molecular dynamics simulations to predict structural changes
Systems biology approaches integrating channel kinetics into cellular models
Machine learning algorithms for pattern recognition in complex datasets
To effectively investigate CACNG6 subunit interactions:
Co-expression systems:
Heterologous expression with titrated subunit ratios
Bicistronic constructs to ensure co-expression
FRET/BRET approaches for direct interaction measurement
Experimental design considerations:
| Approach | Advantages | Limitations | Controls |
|---|---|---|---|
| Co-immunoprecipitation | Detects native complexes | Disruption during lysis | IgG controls, reverse IP |
| FRET | Live cell analysis | Distance constraints | Donor/acceptor-only controls |
| BiFC | High sensitivity | Irreversible | Fragment-only controls |
| Proximity Ligation | Single molecule detection | Antibody specificity | Primary antibody omission |
Functional validation:
Electrophysiological characterization of co-expressed channels
Trafficking assays examining surface expression
Pharmacological sensitivity profiles of assembled complexes
For investigating CACNG6 regulation mechanisms:
Promoter analysis:
Luciferase reporter assays with progressive deletions
ChIP-seq for transcription factor binding
CRISPR interference/activation for functional validation
Epigenetic regulation:
Bisulfite sequencing for DNA methylation analysis
ChIP for histone modifications
ATAC-seq for chromatin accessibility
Post-transcriptional regulation:
RNA stability assays with actinomycin D chase
3'UTR reporter assays for miRNA targeting
RNA immunoprecipitation for RNA-binding protein interactions
CRISPR/Cas9 approaches for CACNG6 research:
Knockout strategies:
Design multiple sgRNAs targeting early exons
Implement careful validation including sequencing and western blotting
Consider potential compensatory upregulation of other gamma subunits
Knockin approaches:
HDR-mediated introduction of tags or mutations
Base editing for specific nucleotide changes
Prime editing for precise modifications without double-strand breaks
Experimental considerations:
| Application | Delivery Method | Validation Approach | Potential Pitfalls |
|---|---|---|---|
| Complete KO | Lentiviral | Sequencing, Western blot | Off-target effects |
| Domain mutation | Electroporation | Functional assays | Mosaic expression |
| Reporter knockin | Lipofection | Live imaging | Silent mutations affecting splicing |
When confronting contradictory results:
Systematic analysis of methodological differences:
Cell type-specific effects (heterologous vs. native systems)
Experimental conditions (recording solutions, temperature)
Protein expression levels and stoichiometry
Reconciliation strategies:
Direct side-by-side comparisons under identical conditions
Collaborative cross-laboratory validation
Preregistration of experimental protocols
Reporting recommendations:
Full methodological transparency
Publication of negative results
Data sharing in standardized formats
Current challenges include:
Antibody specificity:
Limited availability of highly specific antibodies for rat CACNG6
Cross-reactivity with other gamma subunits
Solution: Validate with knockout controls and peptide competition assays
Functional assays:
Difficulty isolating CACNG6-specific effects from other channel components
Variability in recombinant expression systems
Solution: Develop subunit-specific pharmacological tools
Physiological relevance:
Gap between heterologous systems and in vivo function
Incomplete understanding of native subunit composition
Solution: Develop tissue-specific conditional models with careful phenotyping